Pro Share Advisors LLC Summit Therapeutics Inc. Transaction History

Pro Share Advisors LLC

$42.5 Billion
Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 60,830 shares of SMMT stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,830

Previous 59,356 2.48%

Holding current value

$1.31 Million

Previous $1.3 Million 16.47%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$17.52 - $23.46 $25,824 - $34,580	1,474 Added 2.48%	60,830 $1.09 Million
Q3 2024 Nov 13, 2024	BUY	$6.89 - $31.93 $3,438 - $15,933	499 Added 0.85%	59,356 $1.3 Million
Q2 2024 Aug 13, 2024	SELL	$2.39 - $10.92 $26,619 - $121,626	-11,138 Reduced 15.91%	58,857 $459,000
Q1 2024 May 08, 2024	BUY	$2.55 - $5.07 $15,389 - $30,597	6,035 Added 9.44%	69,995 $289,000
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $5,502 - $9,324	3,295 Added 5.43%	63,960 $166,000
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $694 - $1,091	451 Added 0.75%	60,665 $113,000
Q2 2023 Aug 10, 2023	BUY	$1.32 - $2.81 $15,634 - $33,281	11,844 Added 24.49%	60,214 $151,000
Q1 2023 May 11, 2023	BUY	$1.38 - $5.41 $43,772 - $171,599	31,719 Added 190.49%	48,370 $84,000
Q4 2022 Feb 02, 2023	SELL	$0.68 - $5.31 $186 - $1,454	-274 Reduced 1.62%	16,651 $70,000
Q3 2022 Nov 04, 2022	BUY	$0.89 - $1.63 $15,063 - $27,587	16,925 New	16,925 $20,000
Q2 2022 Aug 01, 2022	SELL	$0.92 - $2.38 $13,849 - $35,828	-15,054 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.0 - $3.45 $8,928 - $15,400	-4,464 Reduced 22.87%	15,054 $37,000
Q4 2021 Feb 08, 2022	SELL	$2.45 - $5.64 $11,424 - $26,299	-4,663 Reduced 19.28%	19,518 $52,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $4,235 - $7,252	877 Added 3.76%	24,181 $121,000
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $61,176 - $100,496	11,879 Added 103.97%	23,304 $174,000
Q1 2021 May 14, 2021	SELL	$5.17 - $11.19 $6,571 - $14,222	-1,271 Reduced 10.01%	11,425 $67,000
Q4 2020 Feb 09, 2021	BUY	$3.25 - $6.0 $41,262 - $76,176	12,696 New	12,696 $60,000

Others Institutions Holding SMMT

# of Institutions

231

Shares Held

83.1M

Call Options Held

1.66M

Put Options Held

2.56M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.35B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Summit Therapeutics Inc. Transaction History